United Therapeutics (UTHR) Earnings Analysis
United Therapeutics (UTHR) next reports earnings on 2026-07-29, consensus EPS 7.06 USD. Last quarter (2025-07-30) it missed with EPS 6.41 USD vs 7.29 USD est (-12.1%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 18.01.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does UTHR next report earnings?
| Next earnings date | 2026-07-29 |
|---|---|
| Consensus EPS estimate | 7.06 USD |
| Revenue estimate | 0.81B |
UTHR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-07-30 | 6.41 USD | 7.29 USD | -12.1% | Miss |
| 2025-04-30 | 6.63 USD | 6.29 USD | +5.4% | Beat |
| 2025-02-26 | 6.19 USD | 6.4 USD | -3.3% | Miss |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
UTHR valuation and analyst view
| Trailing P/E | 18.01 |
|---|---|
| Trailing EPS | 29.595 USD |
| Price / book | 3.89 |
| Dividend yield | 0.00% |
| Market cap | 22.38B |
| Analyst consensus | Buy (17 buy / 12 hold / 1 sell) |
| Avg price target | 663 USD |
Related research pages
Frequently asked questions
When is United Therapeutics (UTHR)'s next earnings date?
United Therapeutics is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 7.06 USD and revenue estimate of 0.81B.
Did UTHR beat earnings last quarter?
In its 2025-07-30 report, UTHR posted EPS of 6.41 USD versus a 7.29 USD estimate — a miss of 12.1%.
What is UTHR's earnings track record?
Over the last 3 reported quarters with consensus data, UTHR beat estimates 1 times (33%).
What is UTHR's current P/E ratio and EPS?
UTHR trades at a trailing P/E of 18.01 on trailing EPS of 29.595402298850576 USD.
What do analysts rate UTHR?
Analyst consensus is "Buy" across 30 ratings (0 strong buy, 17 buy, 12 hold, 1 sell, 0 strong sell). Average 12-month price target: 663 USD.